🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Lushang Freda Pharmaceutical Co.,Ltd. (SHA:600223)
China flag China · Delayed Price · Currency is CNY
4.880
-0.200 (-3.94%)
Nov 20, 2026, 3:00 PM CST

SHA:600223 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
2,7572,8952,9481,7344,3185,139
Cash & Short-Term Investments
2,7572,8952,9481,7344,3185,139
Cash Growth
0.21%-1.79%70.04%-59.85%-15.97%1.27%
Accounts Receivable
535.79509.05511.85599.06428.31306.23
Other Receivables
18.5347.6731.673,0621,3071,226
Receivables
554.32556.72543.523,6611,7401,532
Inventory
436.69437.16558.71525.4446,04748,204
Prepaid Expenses
-00.08-491.91608.15
Other Current Assets
160.194.0793.4764.023,0323,187
Total Current Assets
3,9083,9834,1445,98455,62958,670
Property, Plant & Equipment
1,1691,1991,1921,2031,3821,345
Long-Term Investments
180.34187.84168.53191.76926.97874.1
Goodwill
153.74153.74153.74153.74155.59160.33
Other Intangible Assets
177.33168.02163.22148.7196.5210.1
Long-Term Deferred Tax Assets
32.5227.6129.8223.66105.04101.25
Long-Term Deferred Charges
84.0384.0491.1153.9652.3440.51
Other Long-Term Assets
50.4254.2658.7358.2626.2213.92
Total Assets
5,7555,8586,0007,81858,47461,415

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
279.12289.39413.35452.989,2668,694
Accrued Expenses
45.42139.48136.53127.321,003948.47
Short-Term Debt
68.03121.05212.12705.222,2703,219
Current Portion of Long-Term Debt
4.051.0112.51790.343,2222,307
Current Portion of Leases
-4.599.218.165.681.99
Current Income Taxes Payable
30.4319.0816.359.5226.5918.81
Current Unearned Revenue
65.5112.01122.97108.4417,86921,686
Other Current Liabilities
190.96159.52183.3199.7816,94414,217
Total Current Liabilities
683.49846.131,1062,40250,60651,093
Long-Term Debt
5.5644.55665.042,2153,751
Long-Term Leases
2.714.297.5312.9821.377.69
Long-Term Unearned Revenue
5151.8151.2355.1855.6359.17
Long-Term Deferred Tax Liabilities
1.691.892.312.738.555.24
Total Liabilities
744.39910.121,2123,13852,90754,916

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
1,0171,0171,0171,0171,0171,009
Additional Paid-In Capital
614.02614.02612.86612.51617.8616.38
Retained Earnings
2,6552,6022,4752,3852,0822,202
Comprehensive Income & Other
---0.290.33900
Total Common Equity
4,2864,2334,1054,0153,7174,727
Minority Interest
724.81714.95683.47665.371,8501,773
Shareholders' Equity
5,0114,9484,7884,6805,5676,500
Total Liabilities & Equity
5,7555,8586,0007,81858,47461,415

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
80.28136.94285.922,1827,7359,287
Net Cash (Debt)
2,6762,7582,662-448.16-3,417-4,149
Net Cash Growth
4.92%3.62%----
Net Cash Per Share
2.572.642.62-0.44-3.01-4.01
Filing Date Shares Outstanding
1,0171,0171,0171,0171,0171,009
Total Common Shares Outstanding
1,0171,0171,0171,0171,0171,009
Working Capital
3,2243,1373,0373,5835,0237,577
Book Value Per Share
4.224.164.043.953.663.79
Tangible Book Value
3,9553,9113,7883,7123,3654,357
Tangible Book Value Per Share
3.893.853.733.653.313.43
Buildings
-1,0891,0459171,3121,294
Machinery
-738.73681.06620.81604.52551.66
Construction In Progress
-13.9916.12131.3672.9540.99